AstraZeneca (OTCMKTS:AZNCF) Shares Down 1.6%

AstraZeneca PLC (OTCMKTS:AZNCF)’s stock price was down 1.6% during trading on Friday . The company traded as low as $155.14 and last traded at $155.14. Approximately 849 shares were traded during mid-day trading, a decline of 70% from the average daily volume of 2,860 shares. The stock had previously closed at $157.73.

AstraZeneca Stock Performance

The business has a 50 day moving average of $162.79 and a 200 day moving average of $152.23.

AstraZeneca Cuts Dividend

The company also recently announced a dividend, which was paid on Monday, September 9th. Stockholders of record on Friday, August 9th were given a dividend of $1.00 per share. The ex-dividend date was Wednesday, August 7th. AstraZeneca’s dividend payout ratio is currently 343.14%.

Institutional Investors Weigh In On AstraZeneca

An institutional investor recently bought a new position in AstraZeneca stock. Kennedy Capital Management LLC acquired a new position in AstraZeneca PLC (OTCMKTS:AZNCF) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 37,554 shares of the company’s stock, valued at approximately $5,068,000. Hedge funds and other institutional investors own 40.87% of the company’s stock.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.